Cancer is known as the �emperor of the maladies, � and its history is long and widely known. Researchers and doctors across the globe have dedicated themselves to fighting the scourge of cancer and the more they learn about the disease and how it operates, the more they can do to stop it. One particularly nasty form of cancer is known as gastric carcinoma, but researchers in both California and Germany may have found a new way to fight the bacteria that causes it.
Gastric carcinoma is one of the most fatal forms of cancer because it does not present symptoms until the later stages. By the time the cancer is found doctors are already behind on time and must work quickly and aggressively to treat this type of cancer. Scientists knew that some cancers were caused by viruses that deposit transforming genes onto human host cells but how bacteria caused cancers has largely remained a mystery.
An interdisciplinary team from Berlin, Germany, and Stanford, California may have found the action which could pave the way to new directions in research. The team found that the bacteria cause the stomach�s natural stem cell generation to go into overdrive. This abnormal stem cell development is believed to be the link to the link gastric carcinoma. The findings further raise awareness that bacteria and chronic bacterial infections are catalysts to certain types of cancers. By eliminating the stem cell production or figuring a way to mark the bacteria early, scientists may be able to reduce the effects or utilize the patient�s stem cells to battle cancer instead of assisting it.
Current Links Between Stem Cells and Cell-Based Therapies
The new research regarding gastric carcinoma is exciting for the field of stem cell research and joins new developments already in progress. There have already been major advances in the field of mesenchymal stem cell-based therapies with renowned stem cell research Dr. Kenneth Pettine recently completing a three-study testing the efficacy of stem cells in treating chronic degenerative musculoskeletal systems. Pettine founded the Orthopedic Stem Cell Institute in Northern Colorado and has researched the use of stem cells in several other FDA studies.
It is the work of Pettine and the global team of researchers that will make the promises of stem cell-based therapies a reality. It may have taken a while to get from the promises of early stem cell research to where we are now, but new breakthroughs are moving stem cell research into the 21st century where it belongs.